All PlansAdministrativeMedium impact
Recall: Accupril Tablets
UPMC Health Plan·Family Medicine, Internal Medicine, Cardiology +2 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Pfizer is recalling Accupril tablets (Quinapril HCl) in 10mg, 20mg, and 40mg strengths due to nitrosamine contamination above acceptable levels. Healthcare practices should stop dispensing affected batches and notify patients taking these medications.
Action Required
Immediately: Clinical staff should identify patients prescribed Accupril tablets (10mg, 20mg, 40mg) and contact them about the recall. Pharmacy staff must remove affected batches from inventory. Providers should review alternative ACE inhibitors for affected patients and document medication changes in patient records.